African Americans (AAs) are disproportionately affected by certain types of hematologic malignancies. Despite the efforts of investigators, AAs with hematologic malignancies remain grossly underrepresented in cancer clinical trials. Few studies have evaluated the underrepresenta…
"1" Result
Sort By: